Skip to search formSkip to main contentSkip to account menu

Rocuronium

Known as: 1-(17-(acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Background and objectives: This prospective, double‐blind, randomized, placebo‐controlled study was designed to determine the… 
Highly Cited
2003
Highly Cited
2003
Background and objective: Rocuronium and, to a lesser extent, vecuronium can induce burning sensations associated with withdrawal… 
2003
2003
We evaluated the pretreatment of small-dose of ketamine or normal saline in the reduction of withdrawal movements induced by… 
Highly Cited
2002
Highly Cited
2002
We investigated postoperative residual curarization after administration of either vecuronium or rocuronium with reversal by… 
Highly Cited
2002
Highly Cited
2002
Rapid-sequence induction with cricoid pressure is a standard procedure for inducing anesthesia in patients with a potentially… 
Highly Cited
1996
Highly Cited
1996
Background: Rocuronium (Org 9426) was shown to have the fastest onset of action of all currently available non‐depolarizing… 
Highly Cited
1995
Highly Cited
1995
Hypothermia prolongs the time-course of action of non-depolarizing neuromuscular blocking agents. The mechanism, however, is… 
Highly Cited
1994
Highly Cited
1994
Different priming sequences of equipotent doses of rocuronium and mivacurium on the onset of maximum neuromuscular block and… 
Highly Cited
1993
Highly Cited
1993
We determined the dose-response relationship, the onset time, the duration, and the recovery time of a rocuronium neuromuscular…